Does DEFIBROTIDE Cause Gastrointestinal haemorrhage? 125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Gastrointestinal haemorrhage have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 3.3% of all adverse event reports for DEFIBROTIDE.
125
Reports of Gastrointestinal haemorrhage with DEFIBROTIDE
3.3%
of all DEFIBROTIDE reports
71
Deaths
48
Hospitalizations
How Dangerous Is Gastrointestinal haemorrhage From DEFIBROTIDE?
Of the 125 reports, 71 (56.8%) resulted in death, 48 (38.4%) required hospitalization, and 27 (21.6%) were considered life-threatening.
Is Gastrointestinal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFIBROTIDE. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does DEFIBROTIDE Cause?
Off label use (1,323)
Venoocclusive disease (576)
Death (463)
Multiple organ dysfunction syndrome (372)
Venoocclusive liver disease (355)
Intentional product use issue (201)
Hypotension (169)
Haemorrhage (156)
Sepsis (143)
Acute graft versus host disease (140)
What Other Drugs Cause Gastrointestinal haemorrhage?
RIVAROXABAN (20,041)
ASPIRIN (13,172)
CLOPIDOGREL BISULFATE (5,513)
DABIGATRAN ETEXILATE (4,081)
APIXABAN (4,030)
WARFARIN (2,469)
IBUPROFEN (1,496)
ADALIMUMAB (943)
PRADAXA (907)
NAPROXEN (770)
Which DEFIBROTIDE Alternatives Have Lower Gastrointestinal haemorrhage Risk?
DEFIBROTIDE vs DEFLAZACORT
DEFIBROTIDE vs DEGARELIX
DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE
DEFIBROTIDE vs DELAMANID
DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL